A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct ...

The first patient to undergo recently approved gene therapy for sickle cell disease, Kendric Cromer, has left the hospital.

The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus ...

The American Heart Association and the American Stroke Association issued guidelines Monday that also look at the effects of testosterone and estrogen on the body. Meanwhile, Eli Lilly sues three ...

Kamala Harris hit the road today for campaign events in the three battleground states that make up her clearest possible path ...

After 44 days, Kendric Cromer, 12, left the hospital. While his family feels fortunate that he was the first to receive a ...

Legends Concerts return to the grounds of Cromer Hall from July 11 to 13 2025 and you can book day or weekend tickets. Expect top tribute acts on the first two nights, celebrating ABBA ...

Gene Therapy for Hemophilia A and B? Within the past year, considerable progress has been made in the field of gene therapy for hemophilia A and B. [15] This was documented in each of several ...

Forbion, Glide Healthcare and founding investor Syncona Limited also participated in the round. Like many gene therapy developers, the company uses adeno-associated viruses, or AAVs, as the envelope ...

These services bring a host of advanced capabilities that address critical challenges in gene therapy development: • Tissue-Specific Targeting: Tailored AAV vectors designed to target distinct tissue ...

TRENTON, N.J. — U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults. The Food and Drug ...

Cell and gene therapy is the hottest area in biotech at the moment, and Gilead’s $11.9bn acquisition of Kite Pharma in October has been followed by Celgene’s $9bn buyout of Juno Therapeutics.